Physician profile
Choon Hyuck David Kwon
NPI 1811438369
$507,345.73
in general payments reported to CMS, 2019-2025
17 companies · $485K in 2025
The $485K reported for 2025 was more than what 99% of Transplant Surgery providers received nationally (typical 2025 total: $423).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $196 · 2020: $179 · 2021: $7,828 · 2022: $1,539 · 2023: $8,386 · 2024: $4,557 · 2025: $485K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $482K · Travel and Lodging: $6,468 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,100 · Food and Beverage: $3,264.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $481,771.21 |
| Travel and Lodging | $6,467.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,100.00 |
| Food and Beverage | $3,264.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Histosonics, INC. | $485,512.41 | 2024-2025 | |
| Medtronic, INC. | $13,205.16 | 2021-2025 | Signia, Endo Gia Ultra, Ligasure |
| Fujifilm Healthcare Americas Corporation | $2,800.00 | 2021-2022 | |
| Transmedics, INC. | $2,082.48 | 2025 | Organ Care System |
| Intuitive Surgical, INC. | $1,128.78 | 2021-2025 | Da Vinci Surgical System |
| Mimedx Group, INC. | $759.98 | 2024-2025 | |
| Dilon Technologies, INC. | $292.27 | 2023-2024 | Hemoblast Bellows |
| Boston Scientific Corporation | $275.44 | 2022 | |
| Ethicon US, LLC | $225.01 | 2020-2023 | Surgicel Nu-Knit, Evarrest |
| Olympus America INC. | $196.41 | 2019 | |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $155.29 | 2023 | |
| Intera Oncology, INC | $149.99 | 2025 | Intera |
| Rti Surgical, INC | $149.74 | 2024 | |
| Kerecis Limited | $147.10 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Integra Lifesciences Corporation | $143.64 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $105.25 | 2022 | |
| Conmed Corporation | $16.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$47,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Choon Hyuck Kwon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.